Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Tomas Cihlar and John Bilello.
Tomas Cihlar
Connection Strength
0.466
John Bilello
  1. Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV. J Med Chem. 2021 04 22; 64(8):5001-5017.
    View in: PubMed
    Score: 0.235
  2. A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents. Antiviral Res. 2021 08; 192:105122.
    View in: PubMed
    Score: 0.060
  3. Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2021 Jun 21; 12(1):3984.
    View in: PubMed
    Score: 0.060
  4. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2020 10 15; 11(1):5214.
    View in: PubMed
    Score: 0.057
  5. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice. Cell Rep. 2020 07 21; 32(3):107940.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.